Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
FOLVRON is an oral capsule combination of ferrous sulfate and folic acid used to treat or prevent iron and folate deficiency anemia. It is a foundational micronutrient supplement that addresses dual nutritional deficiencies common in pregnancy, malnutrition, and chronic disease. The product works by replenishing depleted iron stores and supporting red blood cell formation through folate cofactors.
As an established generic-adjacent product approaching LOE, commercial teams are likely small and focused on retention rather than growth, with limited career development trajectory.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on FOLVRON offers limited career growth in a mature, declining franchise with minimal innovation and few linked job openings. Positions are primarily focused on defending market share and managing relationships rather than driving strategic initiatives or learning cutting-edge pharma skills.
Worked on FOLVRON at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.